FILINGS
| ALNY 0001178670 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2022-04-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-04-04 | 8-K | 8-K | View Document |
| 2022-03-17 | 8-K | 8-K | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-14 | SC 13G | View Document | |
| 2022-02-11 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-10 | 10-K | 10-K | View Document |
| 2022-02-10 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2022-02-09 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-09 | 3 | PRIMARY DOCUMENT | View Document |
| 2022-02-09 | SC 13G/A | SCHEDULE 13G/A | View Document |
| 2022-02-09 | SC 13G/A | View Document | |
| 2022-02-04 | SC 13G/A | SEC SCHEDULE 13G | View Document |
| 2022-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-03 | SC 13G/A | View Document | |
| 2022-01-18 | SC 13G/A | View Document | |
| 2022-01-10 | 8-K | 8-K | View Document |
| 2022-01-04 | 8-K | 8-K | View Document |
| 2022-01-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-01-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-01-04 | 3 | PRIMARY DOCUMENT | View Document |
| 2021-12-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-12-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-12-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-12-20 | 8-K | 8-K | View Document |
| 2021-12-14 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-11-12 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-10-29 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-10-28 | 10-Q | 10-Q | View Document |
| 2021-10-28 | 8-K | 8-K | View Document |
| 2021-09-08 | 8-K | 8-K | View Document |
| 2021-08-16 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-08-11 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-08-09 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-08-09 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-08-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-08-03 | 10-Q | 10-Q | View Document |
| 2021-08-03 | 8-K | 8-K | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-19 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-07-14 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-11 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-05-21 | 8-K | 8-K | View Document |
| 2021-05-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-04-29 | 10-Q | 10-Q | View Document |
| 2021-04-29 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2021-04-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-04-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-04-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-04-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-04-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-04-12 | 8-K | 8-K | View Document |
| 2021-04-02 | DEFA14A | DEFA14A | View Document |
| 2021-04-02 | DEF 14A | DEF 14A | View Document |
| 2021-03-18 | SEC STAFF LETTER | View Document | |
| 2021-03-10 | 3 | PRIMARY DOCUMENT | View Document |
| 2021-02-26 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-26 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-26 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-26 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-26 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-18 | SEC STAFF LETTER | View Document | |
| 2021-02-16 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-16 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-16 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-16 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-11 | S-8 | S-8 | View Document |
| 2021-02-11 | 10-K | 10-K | View Document |
| 2021-02-11 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | View Document |
| 2021-02-08 | SC 13G/A | View Document | |
| 2021-02-03 | SC 13G/A | SEC SCHEDULE 13G | View Document |
| 2021-02-01 | SC 13G/A | View Document | |
| 2021-01-29 | SC 13G/A | View Document | |
| 2021-01-15 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-01-14 | SC 13G/A | View Document | |
| 2021-01-13 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-01-13 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-01-11 | 8-K | 8-K | View Document |
| 2020-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2020-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2020-11-30 | 4 | PRIMARY DOCUMENT | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
